# Mirabegron in Patients With Age-Related Macular Degeneration

> **NCT07305298** · — · NOT_YET_RECRUITING · sponsor: **University of Naples** · enrollment: 312 (estimated)

## Conditions studied

- Dry AMD
- Overactive Bladder

## Interventions

- **DRUG:** Mirabegron 50mg
- **DRUG:** Solifenacin 5mg

## Key facts

- **NCT ID:** NCT07305298
- **Lead sponsor:** University of Naples
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305298, "Mirabegron in Patients With Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07305298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*